Background WHO recommends routine use of rotavirus vaccines in all countries, particularly
in those with high mortality attributable to diarrhoeal diseases. To establish the burden of life …

Background As new rotavirus vaccines are being introduced in immunization programs,
global and national estimates of disease burden, especially rotavirus-associated mortality …

Background Approximately 39% of the global diarrhoea deaths in children aged 5 years
may be attributable to rotavirus infection. Two rotavirus vaccines were recently introduced to …

Background Rotavirus vaccine use in national immunisation programmes has led to
declines in hospital admissions for rotavirus gastroenteritis among children; however, the …

Background. Rotavirus vaccine is recommended for routine use in all countries globally. To
facilitate decision making on rotavirus vaccine adoption by countries, help donors prioritize …

In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus
vaccination on hospitalizations and deaths from rotavirus and all-cause acute gastroenteritis …

Importance Rotavirus infection is the global leading cause of diarrhea-associated morbidity
and mortality among children younger than 5 years. Objectives To examine the extent of …

Background Since 2006, more than 100 countries have introduced rotavirus vaccine into
their immunization programs. We reviewed published data on relative reductions of rotavirus …

Introduction: Rotavirus is the leading cause of hospitalizations and deaths from diarrhea. 33
African countries had introduced rotavirus vaccines by 2016. We estimate reductions in …

Background The effectiveness of the rotavirus vaccine under conditions of routine use in an
African setting with a high prevalence of HIV infection needs to be established. We assessed …